Amanote Research
Register
Sign In
Serum Level of Endogenous Secretory Receptor for Advanced Glycation End Products and Other Factors in Type 2 Diabetic Patients With Mild Cognitive Impairment
Diabetes Care
- United States
doi 10.2337/dc11-0958
Full Text
Open PDF
Abstract
Available in
full text
Categories
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Date
October 19, 2011
Authors
G. Chen
L. Cai
B. Chen
J. Liang
F. Lin
L. Li
L. Lin
J. Yao
J. Wen
H. Huang
Publisher
American Diabetes Association
Related search
Association Between Serum Endogenous Secretory Receptor for Advanced Glycation End Products and Risk of Type 2 Diabetes Mellitus With Combined Depression in the Chinese Population
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Endogenous Secretory Receptor for Advanced Glycation End Products and Chronic Kidney Disease in the Elderly Population
American Journal of Nephrology
Nephrology
Serum Levels of Advanced Glycation End Products in Type II Diabetic Patients With Acute Cerebral Infarction
Biomedical Research
Factors Associated With Poor Glycaemic Control in Type 2 Diabetic Elderly Patients With Mild Cognitive Impairment
Journal of Pre-Clinical and Clinical Research
Erratum To: Endogenous Soluble Receptor of Advanced Glycation End-Products (esRAGE) Is Negatively Associated With Vascular Calcification in Non-Diabetic Hemodialysis Patients
International Urology and Nephrology
Urology
Nephrology
Correlation Between Advanced Glycation End-Products and the Expression of Fatty Inflammatory Factors in Type II Diabetic Cardiomyopathy
Bosnian Journal of Basic Medical Sciences
Medicine
Reduced Soluble Receptor for Advanced Glycation End-Products in COPD
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy
Open Access Macedonian Journal of Medical Sciences
Medicine
Receptor-Mediated Endothelial Cell Dysfunction in Diabetic Vasculopathy. Soluble Receptor for Advanced Glycation End Products Blocks Hyperpermeability in Diabetic Rats.
Journal of Clinical Investigation
Medicine
